Infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects who met the diagnostic criteria of infertility and could exclude low ovarian response; 2. Women aged between 20 and 38; 3. Subjects undergoing IVF / ICSI / PGD assisted pregnancy and those planning embryo transfer; 4. IVF / ICSI transferred 1-2 D3 cleavage embryos or blastocysts with good quality, while PGD blastocysts only transferred 1; 5. Those subjects who have informed consent and are willing to accept clinical trial observers.
Exclusion criteria
Exclusion criteria: 1. Patients with por diagnosis; 2. Patients with endometrial lesions (including endometritis, endometrial polyps and intrauterine adhesions); 3. Patients with uterine malformation (single horn uterus, double horn uterus, double uterus, mediastinal uterus); 4. Patients with organic lesions of reproductive organs, such as adenomyosis, hysteromyoma and ovarian cyst; 5. Patients with submucous myoma and intramural myoma that oppresses uterine cavity line; 6. Abnormal karyotype of the patient or her husband; 7. Patients with contraindications of assisted reproductive technology or pregnancy; 8. Patients with serious primary diseases and mental diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 9. Patients who have received treatment (such as acupuncture and traditional Chinese Medicine) related to regulating menstruation and helping pregnancy in recent 3 months; 10. Patients who are participating in other clinical drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| persistent pregnancy rate;endometrial receptivity; | — |
Countries
China
Contacts
Beijing Chaoyang Hospital Affiliated to Capital Medical University